Skip to content

Effect of Hyaluronic Acid on the Therapy of Alveolar Osteitis

Effect of Hyaluronic Acid on the Therapy of Alveolar Osteitis - A Double-blind, Randomized Controlled Clinical Trial

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04853589
Enrollment
60
Registered
2021-04-21
Start date
2021-05-01
Completion date
2023-05-01
Last updated
2022-09-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Alveolar Osteitis

Brief summary

Alveolar osteitis (AO; syn. dry socket) is one of the most frequent complications following tooth removal and it is defined as presence of severe postoperative pain in and around the extraction site, which increases in severity at any time between one and three days after extraction, accompanied by a partially or completely disintegrated blood cloth within the alveolar socket, with or without halitosis, and at the same time excluding any other cause for the pain (Blum 2002). To enhance standard treatment of AO, which consists of curettage of the dry socket, rinsing with saline solution, and inducing bleeding from the exposed alveolar bone walls, numerous products have been tested. One of them is hyaluronic acid (HY). The aim of the present study is to investigate the potential effect of HY gel application in the treatment of AO. Specifically, the application of HY only (HY test group; n = 20) or the combination of HY and an absorbable collagen sponge (HY+C test group; n = 20) will be compared to standard treatment (blood clot; control group, n=20). Clinical and patient related outcome parameters will be recorded for up to 14 days after treatment. A more stable blood clot and thus improved wound healing with faster pain reduction is expected through the use of HY.

Interventions

After the local anesthesia is injected, alveolar curettage is performed, and the socket is rinsed with saline solution. Prior to wound closure, patients from the test group 1 will receive hyaluronic acid gel.

After the local anesthesia is injected, alveolar curettage is performed, and the socket is rinsed with saline solution. Prior to wound closure, patients from the test group 2 will receive hyaluronic acid gel together with a collagen carrier.

Sponsors

Medical University of Vienna
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 99 Years
Healthy volunteers
No

Inclusion criteria

1. \> 18 years; 2. Untreated AO after extraction of a permanent tooth (excluding wisdom teeth); 3. Diagnosis of AO based on the criteria of Blum (Blum 2002)

Exclusion criteria

4. Patients with chronic diseases and/or taking any medication, influencing hard and soft tissue healing; 5. Pregnancy; 6. History of hypersensitivity or allergy to HY; 7. Inability to attend follow-up appointments; Intake of preoperative antibiotics.

Design outcomes

Primary

MeasureTime frameDescription
Pain perception by the patient2 weeksVAS- Visual analogue scale measured on a 10cm scale, where 0 represents no pain and 10 represents maximum pain

Countries

Austria

Contacts

Primary ContactDanijel Domic, DMD
Danijel.domic@meduniwien.ac.at+4369917230592

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026